Stockscreener 앱 받기
8.15
4.12%
-0.35
전일 마감가:
$8.50
열려 있는:
$8.58
하루 거래량:
946.85K
Relative Volume:
0.85
시가총액:
$713.22M
수익:
-
순이익/손실:
$-95.90M
주가수익비율:
-6.1742
EPS:
-1.32
순현금흐름:
$-79.09M
1주 성능:
-0.97%
1개월 성능:
+9.10%
6개월 성능:
+280.84%
1년 성능:
+10.06%
1일 변동 폭
$8.08
$8.6214
1주일 범위
$7.976
$8.7799
52주 변동 폭
$1.865
$8.7799
턴스 파마슈티컬스 Stock (TERN) Company Profile
명칭
Terns Pharmaceuticals Inc
전화
650-525-5535 EXT.101
주소
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
8.15 | 743.84M | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
턴스 파마슈티컬스 Stock (TERN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-17 | 개시 | Barclays | Overweight |
| 2025-09-04 | 재개 | H.C. Wainwright | Neutral |
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2024-10-31 | 개시 | Oppenheimer | Outperform |
| 2023-06-22 | 개시 | Mizuho | Buy |
| 2023-06-07 | 개시 | Jefferies | Buy |
| 2023-05-31 | 개시 | ROTH MKM | Buy |
| 2023-05-08 | 개시 | BMO Capital Markets | Outperform |
| 2023-02-14 | 개시 | JMP Securities | Mkt Outperform |
| 2023-02-07 | 개시 | UBS | Buy |
| 2022-09-12 | 개시 | H.C. Wainwright | Neutral |
| 2021-09-14 | 재개 | Goldman | Buy |
| 2021-03-02 | 개시 | Cowen | Outperform |
| 2021-03-02 | 개시 | Goldman | Buy |
| 2021-03-02 | 개시 | JP Morgan | Overweight |
모두보기
턴스 파마슈티컬스 주식(TERN)의 최신 뉴스
Terns Pharmaceuticals stock hits 52-week low at $4.16 - MSN
Published on: 2025-10-12 21:16:00 - newser.com
What analysts say about Terns Pharmaceuticals Inc stockMean Reversion Trades & Secret Picks Wall Street Isn’t Talking About - earlytimes.in
Detecting price anomalies in Terns Pharmaceuticals Inc. with AIPortfolio Gains Summary & Expert Approved Momentum Ideas - newser.com
Using data models to predict Terns Pharmaceuticals Inc. stock movementQuarterly Growth Report & Free Safe Capital Growth Stock Tips - newser.com
Is it too late to sell Terns Pharmaceuticals Inc.2025 Year in Review & High Accuracy Trade Alerts - newser.com
Terns Pharmaceuticals Inc Stock Analysis and ForecastCup and Handle Formations & Interactive Charts for Smarter Trading - earlytimes.in
How Terns Pharmaceuticals Inc. stock valuations compare to rivalsMarket Movement Recap & Long-Term Investment Growth Plans - newser.com
How to recover losses in Terns Pharmaceuticals Inc. stockWeekly Stock Recap & Growth Focused Entry Reports - newser.com
Terns Pharmaceuticals (NASDAQ:TERN) Receives Sell (D-) Rating from Weiss Ratings - Defense World
Predicting Terns Pharmaceuticals Inc. trend using moving averages2025 Key Lessons & Fast Gain Stock Tips - newser.com
Volume spikes in Terns Pharmaceuticals Inc. stock – what they meanJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule ... - Enidnews.com
118,000-share grant: Terns Pharmaceuticals awards inducement options at $7.81 with 10-year term - Stock Titan
MarketsMedicine Hat News - FinancialContent
Does Terns Pharmaceuticals Inc. qualify in momentum factor screeningPortfolio Gains Report & Long Hold Capital Preservation Plans - newser.com
We're Hopeful That Terns Pharmaceuticals (NASDAQ:TERN) Will Use Its Cash Wisely - Yahoo Finance
Terns Pharmaceuticals: Valued As If It Can't Win - Seeking Alpha
Is Terns Pharmaceuticals Inc a good long term investmentRisk Adjusted Returns & High Yield Stock Picks - earlytimes.in
Will Terns Pharmaceuticals Inc. stock see insider buyingDollar Strength & Daily Entry Point Alerts - The British Mountaineering Council
Exchange Traded Concepts LLC Grows Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Full technical analysis of Terns Pharmaceuticals Inc. stockTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Goldman Sachs Group Inc. Has $1.15 Million Stock Position in Terns Pharmaceuticals, Inc. $TERN - Defense World
Technical analysis overview for Terns Pharmaceuticals Inc. stockWeekly Trade Summary & Verified Short-Term Trading Plans - newser.com
Can Terns Pharmaceuticals Inc. rally from current levels2025 Momentum Check & Daily Stock Momentum Reports - newser.com
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
2 Under-the-Radar Stocks That Could Soar - Mitrade
Fed Meeting: Is Terns Pharmaceuticals Inc a top pick in the sectorJuly 2025 Opening Moves & Fast Gain Swing Alerts - خودرو بانک
Aug Wrap: Is Terns Pharmaceuticals Inc stock a good dividend stockWeekly Stock Analysis & Fast Exit Strategy with Risk Control - خودرو بانک
Analyzing Terns Pharmaceuticals Inc. with multi timeframe charts2025 Key Lessons & Fast Exit and Entry Trade Guides - newser.com
How high can Terns Pharmaceuticals Inc. stock goQuarterly Portfolio Report & Consistent Return Strategy Ideas - newser.com
Published on: 2025-09-19 23:29:17 - خودرو بانک
Profit Review: Will Terns Pharmaceuticals Inc benefit from current market trendsJuly 2025 Fed Impact & Precise Entry and Exit Recommendations - خودرو بانک
Trend analysis for Terns Pharmaceuticals Inc. this weekBreakout Watch & Real-Time Volume Analysis Alerts - newser.com
Identifying reversal signals in Terns Pharmaceuticals Inc.Quarterly Profit Report & Advanced Swing Trade Entry Alerts - newser.com
Statistical indicators supporting Terns Pharmaceuticals Inc.’s strength2025 Price Targets & Smart Swing Trading Techniques - newser.com
Terns Pharmaceuticals (NASDAQ:TERN) Is In A Good Position To Deliver On Growth Plans - 富途牛牛
Buy Signal: How cyclical is First Bancorp’s revenue streamTake Profit & AI Enhanced Execution Alerts - khodrobank.com
Short Covering: Is Aviat Networks Inc. subject to activist investor interestMarket Growth Review & Stock Timing and Entry Methods - khodrobank.com
Terns Pharmaceuticals (NASDAQ:TERN) Research Coverage Started at Barclays - Defense World
What’s the recovery path for long term holders of Terns Pharmaceuticals Inc.2025 Top Gainers & High Conviction Buy Zone Alerts - newser.com
AI Stocks: Is Terns Pharmaceuticals Inc stock risky to hold nowJuly 2025 PreEarnings & Weekly Chart Analysis and Trade Guides - خودرو بانک
턴스 파마슈티컬스 (TERN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
턴스 파마슈티컬스 주식 (TERN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Kuriakose Emil | Chief Medical Officer |
Jul 01 '25 |
Sale |
4.27 |
853 |
3,640 |
52,464 |
| Gengos Andrew | Chief Financial Officer |
Jun 27 '25 |
Buy |
3.93 |
10,000 |
39,283 |
25,000 |
| Burroughs Amy L. | Chief Executive Officer |
Jun 25 '25 |
Buy |
3.87 |
23,314 |
90,230 |
47,083 |
| Gengos Andrew | Chief Financial Officer |
Jun 13 '25 |
Buy |
3.73 |
10,000 |
37,350 |
10,000 |
| Gengos Andrew | Chief Financial Officer |
Jun 16 '25 |
Buy |
3.95 |
5,000 |
19,732 |
15,000 |
| Kuriakose Emil | Chief Medical Officer |
Apr 01 '25 |
Sale |
2.49 |
952 |
2,366 |
53,317 |
| Jung Melita Sun | Chief Business Officer |
Nov 30 '24 |
Buy |
5.11 |
2,250 |
11,498 |
2,250 |
| Burroughs Amy L. | Chief Executive Officer |
Nov 30 '24 |
Buy |
5.11 |
510 |
2,606 |
19,609 |
| Kuriakose Emil | Chief Medical Officer |
Jan 02 '25 |
Sale |
5.71 |
4,481 |
25,607 |
54,269 |
| Vignola Mark J. | Chief Financial Officer |
Jan 06 '25 |
Sale |
5.80 |
9,059 |
52,500 |
74,752 |
5.74%
자본화:
|
볼륨(24시간):